DGAP-News: Burcon NutraScience Corp.: Burcon NutraScience Engages Liolios Group to Lead New Investor Relations Program
(firmenpresse) - DGAP-News: Burcon NutraScience Corp. / Key word(s): Miscellaneous
Burcon NutraScience Corp.: Burcon NutraScience Engages Liolios Group
to Lead New Investor Relations Program
09.04.2013 / 11:00
---------------------------------------------------------------------
Burcon NutraScience Engages Liolios Group to Lead New Investor Relations
Program
Company at Inflection Point in Commercial Roll-out of Breakthrough in Plant
Protein Quality
Vancouver, British Columbia, April 8, 2013- Burcon NutraScience Corporation
(TSX :BU, NASDAQ:BUR), a world leader in plant protein extraction and
purification technologies, has engaged Liolios Group to lead a new investor
relations and financial communications campaign.
'With our manufacturing and marketing partner, Archer Daniels Midland,
initiating production and sales of our patented soy-based CLARISOY(TM)
protein, and our new Peazazz(TM) pea protein semi-works facility on track
to begin commercial-level production in June, Burcon has arrived at a
turning point in its development,' said Johann Tergesen, president and COO
of Burcon.
These accomplishments, supported by recent industry awards and key U.S.
patents, have propelled Burcon into an industry-leading position as a
developer of premium plant protein ingredients that demonstrate exceptional
clarity, solubility, clean taste, sustainability, manufacturing scalability
and value delivered to a growing demographic of health-conscious consumers.
'Given these compelling factors, we believe the time has come to engage an
experienced team of investor relations professionals to help us communicate
our story to the financial community,' continued Tergesen. 'Liolios Group
brings a proven track record of helping companies like Burcon enhance its
shareholder value by delivering the right message to the right audience,
and building high quality, long-term relationships in the investment
community.'
Liolios Group will work closely with Burcon's management to refine and
deliver the company's message, and make introductions to key investors and
influencers in the financial community. They will also assist the company
in scheduling road shows and financial conferences over the next 12 months.
To arrange for a call or meeting with management, contact John MacLennan at
(416) 644-8688 or john(at)liolios.com.
About Liolios Group Inc.
Liolios Group is a highly selective and comprehensive investor relations
firm specializing in micro to mid-cap companies. The firm aims to deliver
superior performance in corporate messaging and positioning, investor
awareness, analyst and financial press coverage and capital attraction.
Founded in 1999, Liolios Group executives have extensive experience in
financial and investments and represent clients in a wide range of
industries, including life sciences/healthcare, consumer/internet retail,
business services, digital, media/software, clean technology, technology,
natural resources and special situations.
For more information about Liolios Group, visit www.liolios.com.
About Burcon NutraScience Corporation
Burcon NutraScience is a leader in nutrition, health and wellness in the
field of functional plant proteins. The company has developed a portfolio
of composition, application, and process patents originating from a core
protein extraction and purification technology. Burcon has developed:
CLARISOY(TM) soy protein - now licensed to Archer Daniels Midland Company -
which offers clarity and high-quality protein nutrition for low pH beverage
systems and exceptionally clean flavor at any pH; Peazazz(TM) a uniquely
soluble and clean-tasting pea protein; and Puratein(R), Supertein(TM) and
Nutratein(TM) are canola protein isolates with unique functional and
nutritional attributes. For more information about the company, visit
www.burcon.ca.
CLARISOY is a trademark of Archer Daniels Midland Company.
The TSX has not reviewed and does not accept responsibility for the
adequacy of the content of the information contained herein. This press
release contains forward-looking statements or forward-looking information.
Forward-looking statements or forward-looking information involve risks,
uncertainties and other factors that could cause actual results,
performances, prospects and opportunities to differ materially from those
expressed or implied by such forward-looking statements. All statements
other than statements of historical fact included in this release are
forward-looking statements, including, without limitation, statements
regarding plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release. There can be no assurance that such statements will prove to
be accurate and actual results and future events could differ materially
from those anticipated in such statements or information. Important factors
that could cause actual results to differ materially from Burcon's plans
and expectations include the actual results of marketing activities,
adverse general economic, market or business conditions, regulatory changes
and other risks and factors detailed herein and from time to time in the
filings made by Burcon with securities regulators and stock exchanges,
including in the section entitled 'Risk Factors' in Burcon's annual
information form dated June 25, 2012. Any forward-looking statement or
information only speaks as of the date on which it was made and, except as
may be required by applicable securities laws, Burcon disclaims any intent
or obligation to update any forward-looking statement, whether as a result
of new information, future events or otherwise. Although Burcon believes
that the assumptions inherent in the forward-looking statements are
reasonable, forward-looking statements are not guarantees of future
performance and accordingly undue reliance should not be put on such.
Media&Industry Contact:
Michael Kirwan
Director, Corporate Development
Burcon NutraScience Corporation
(604) 733-0896
(888) 408-7960 toll-free
mkirwan(at)burcon.ca
www.burcon.ca
Investor Relations Contact:
John MacLennan
Tel (416) 644.8688 or (949) 574-3860
john(at)liolios.com
End of Corporate News
---------------------------------------------------------------------
09.04.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
206432 09.04.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.04.2013 - 11:00 Uhr
Sprache: Deutsch
News-ID 247039
Anzahl Zeichen: 5303
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 213 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Burcon NutraScience Corp.: Burcon NutraScience Engages Liolios Group to Lead New Investor Relations Program"
steht unter der journalistisch-redaktionellen Verantwortung von
Burcon NutraScience Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
